Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease - Jorge Alberto Cortés; Diego Andrés Rodríguez-Lugo; Martha Carolina Valderrama-Rios; Ricardo Rabagliati; Domenico Capone; Carlos Arturo Álvarez-Moreno; Fabio Varón-Vega; Laura Cristina Nocua-Báez; Cándida Diaz-Brochero; Leonardo Enciso Olivera; Sonia Isabel Cuervo-Maldonado; THOMPSON MOYA, LUIS ADALBERTO; et al. (Elsevier BV, 2025)
Keywords: antifungal agents; evidence-based medicine; hematologic neoplasms; humans; immunocompromised host; invasive pulmonary aspergillosis; amphotericin b lipid complex; caspofungin; micafungin; posaconazole; voriconazole; antifungal agent; antifungal resistance; article; cancer patient; clinical outcome; clinical pathway; clinical practice guideline; consensus; diagnostic procedure; evidence based clinical standard; evidence based practice; health care quality; hematologic malignancy; human; invasive pulmonary aspergillosis; medical expert; south and central america; complication; diagnosis; drug therapy; evidence based medicine; hematologic disease; immunocompromised patient; invasive pulmonary aspergillosis; practice guideline; antifungal agents; hematologic neoplasms; invasive pulmonary aspergillosis; latin america